The ASA has made a submission to the ACCC opposing the proposed re-authorisation of Honeysuckle Health and nib’s collective contracting arrangements.
The ASA is concerned that these arrangements could increase insurer market power, reduce competition, limit patient choice, and place further pressure on anaesthetists and other medical specialists. The submission also highlights risks for regional and rural communities, where reduced provider choice and ongoing private service closures may worsen access to timely care.
The ASA argues that the claimed public benefits have not been demonstrated and that the ACCC should undertake a fresh assessment based on current market conditions and the actual outcomes of the previous authorisation period.
Read our submission on the ASA website here.
For more about Honeysuckle Health Ltd and nib health funds limited application visit the ACCC website here.